ArticleJIMD reports2022

Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosis.

Maria Helena Vaisbich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.